Analytical and clinical evaluation of the Immulite® estradiol assay in serum from patients undergoing in vitro fertilization: Estradiol increase in mature follicles

Clinical Chemistry

Volumn 43, Issue 7, 1997, Pages 1165-1171

  Dancoine, François ^a   Couplet, Gisèle ^a   Buvat, Jacques ^b   Guittard, Catherine ^b   Marcolin, Gérard ^b   Fourlinnie, Jean Claude ^a  

^a Lab de Biol Med Drs Leduc et Ass   (France)

^b NONE   (France)

Author keywords

Chemiluminescence; Embryo transfer; Follicular growth; Radioimmunoassay

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS MEDROXYPROGESTERONE ACETATE; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; INDUCTOR; TRIPTORELIN; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ARTICLE; AUTOMATION; CHEMOLUMINESCENCE; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FERTILIZATION IN VITRO; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; RADIOIMMUNOASSAY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030836717     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.7.1165     Document Type: Article

References (21)

1. Suchanek E, Huderer K, Dobec D, Hlavati V, Simunic V, Grizelj V. Number of follicles, oocytes and embryos in human in vitro fertilization is relative to serum estradiol and progesterone patterns during different types of ovarian hyperstimulation. Eur J Obstet Gynecol Reprod Biol 1994;56:121-7.
2. Ben-Nun I, Shulman A, Ghetler Y, Shilon M, Kaneti H, Beyth Y. The significance of 17-β estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment. J Assist Reprod Genet 1993;10:213-5.
3. Rapi S, Fuzzi B, Mannelli M, Pratesi S, Criscuoli L, Pellegrini S, et al. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17-β estradiol RIA in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity. Acta Eur Fertil 1992;23:63-8.
4. Dor J, Seidman DS, Ben-Shlomo I, Levran D, Karasik A, Mashiach S. The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J Assist Reprod Genet 1992;9:228-32.
5. Firmin C, Antoine JM, Millot F, Alvarez S, Debray M, Tibi C, et al. Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization. Hum Reprod 1991;6:653-8.
6. Levran D, Lopata A, Nayudu PL, Martin MJ, McBain JC, Bayly CM, et al. Analysis of the outcome of in-vitro fertilization in relation to the timing of human chorionic gonadotropin administration by the duration of estradiol rise in stimulated cycles. Fertil Steril 1985; 44:335-41.
7. Dor J, Ben-Shlomo I, Levran D, Rudak E, Yunish M, Mashiach S. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,009 cycles of in vitro fertilization. Fertil Steril 1992;58:986-90.
8. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intra-Fallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-96.
9. Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centers. Hum Reprod 1992;7:49-63.
10. Chetkowski RJ, Kruse LR, Mass TE. Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization. Fertil Steril 1992;52:250-5.
11. Tummon IS, Daniel SA, Kaplan BR, Nisker JA, Yuzpe AA. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 cycles of in vitro fertilization. Fertil Steril 1992;58:563-8.
12. Abdalla HI, Ahuja KK, Leonard T, Morris NN, Honour JW, Jacobs HS. Comparative trial of luteinizing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program. Fertil Steril 1990;53:473-8.
13. Balasch J, Martinez F, Jove I, Cabre L, Coroleu B, Barri PN, et al. Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod 1993;8:1148-51.
14. Lockwood GM, Pinkerton SM, Barlow DH. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum Reprod 1995;10: 293-8.
15. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4.
16. Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136-40.
17. Morris RS, Paulson RJ, Sauer MV, Lobo RA. Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod 1995;10: 811-4.
18. Cook NC, Read GF. Oestradiol measurement in women on oral replacement therapy: the validity of commercial test kits. Br J Biomed Sci 1995;52:97-101.
19. Babson AL. The Cirrus IMMULITE automated immunoassay system. J Clin Immunoassay 1991;14:84-8.
20. Schaap AP, Akhavan H, Romano LJ. Chemiluminescent substrates for alkaline phosphatase: application to ultrasensitive enzyme-linked immunoassays and DNA probes. Clin Chem 1989; 35:1863-4.
21. Vankrieken L, De Hertogh R. Rapid, automated quantification of total-human chorionic gonadotropin in serum by a chemiluminescent enzyme immunometric assay. Clin Chem 1995;41:36-40.